ReviewJournal of human hypertension2026

Aprocitentan in resistant hypertension with chronic kidney disease: balancing albuminuria reduction against early volume risk.

Lucas Maciel de Almeida Corrêa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.